Barclays »

Skye Bioscience shares owned by Barclays

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by Barclays

Quarter filed Position value Share count Share price at filing
2024-06-30 $340k 42k 8.03

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Fund (IWM)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Opt Call Option (TSLA)
Ishares Tr Fund (HYG)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)
Texas Instruments Incorporated (TXN)
Alphabet Inc Class C cs (GOOG)

View all positions for Barclays

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Altium Capital Management
Logos Global Management
Sphera Funds Management
BlackRock
Henderson Group
Vanguard Group
CVI Holdings
Driehaus Capital Management
Point72 Asset Management
Baker Bros. Advisors
Perceptive Advisors
Schonfeld Strategic Advisors
Geode Capital Management

View all funds holding Skye Bioscience